Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cipros 10 association in dyslipidemia
NCT03527069Phase 3Completed
- Sponsor
- EMS
- Start
- Jan 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cipros 10 association in dyslipidemia, hypertriglyceridemia, sponsored by EMS. Started Jan 2021; status: completed.
02
Drugs
Cipros 10 association
03
Conditions
dyslipidemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT03527069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527069.